课题基金 / 基金详情

TUMOR CELL ADHESIVE GLYCOPROTEINS AND METASTASIS

TUMOR CELL ADHESIVE GLYCOPROTEINS AND METASTASIS
肿瘤细胞粘附糖蛋白与转移
批准号:
3190611
负责人:
KENNETH V HONN
金额:
$14.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-05-01 至 1992-04-30

项目摘要

项目成果

KENNETH V HONN的其他基金

相似基金

相关文献

中文摘要
翻译
临床和基础科学领域的众多研究人员 已经假设了血小板、血小板血栓和/或 凝血级联在肿瘤细胞的转移中起着重要作用。 一种被提出的机制是血小板增强肿瘤细胞 与内皮细胞或内皮下基质的黏附 转移性级联的停滞期。然而,一个因果关系 上述肿瘤细胞与血小板的关系 互动尚未建立。相当多的信息 确实存在血小板糖蛋白在血小板中的作用 附着在血管壁上。血小板的因果作用 糖蛋白Lb和糖蛋白LLb/111a与血小板黏附 内皮下基质牢固地建立起来。我们最近做了 获得了免疫相关病毒存在的证据 几种肿瘤细胞系表面的糖蛋白(LR-GP)。 在目前的提案中,我们将测试以下工作 假设。首先,血小板膜糖蛋白Lb和LLb/111a (Gpllb/111a)在肿瘤细胞-血小板相互作用中发挥重要作用 如肿瘤细胞诱导的血小板聚集和血小板 增强肿瘤细胞与内皮细胞的黏附,细胞外 矩阵和/或其单个组件。第二,肿瘤细胞 具有Lr的表面糖蛋白,如果不相同的话 血小板GPIb和Gpllb/111a以及这些肿瘤细胞 糖蛋白(LR Gplb;LR Gpllb/111a)在肿瘤中起主要作用 细胞诱导的血小板聚集,肿瘤细胞与 内皮细胞和肿瘤细胞与内皮细胞的黏附 细胞外基质和/或其单独成分。 初步数据表明,这些糖蛋白存在于 免疫荧光法检测肿瘤细胞表面 免疫电子显微镜分析。此外,还有一个角色, 血小板膜糖蛋白和肿瘤细胞糖蛋白 这两种细胞类型之间的相互作用及其随后的 已经获得了相互作用。其他证据表明 肿瘤细胞骨架可能调节其表达和功能 这些肿瘤细胞膜糖蛋白。在这份提案中,我们 将确定LR GPIb和Gpllb/111a在肿瘤细胞中的作用 与内皮细胞、细胞外基质及其受体的黏附 静态条件下和流动下的单个组件 表现出不同剪切率的条件。此外,我们还将 测定血小板GPIb和Gpllb/111a在血小板中的作用 肿瘤细胞相互作用与血小板促进肿瘤细胞黏附 与生物相关的底物。肿瘤细胞的作用 这些过程中的细胞骨架也将被检查。血小板 GPIB是凝血酶的受体。因此,我们将 确定肿瘤细胞LR Gplb是否具有凝血酶功能 受体和IF凝血酶对肿瘤表达的影响 并影响其与Gpllb/111a细胞的功能关系。 细胞外基质。最后我们将确定这些肿瘤是否 细胞糖蛋白异源表达于细胞表面 不同的转移能力和瞬时表达 细胞暴露在不同的环境条件下。这项建议 因此,将寻求为这些项目建立功能意义 生物过程中的糖蛋白(如黏附等)相关 到肿瘤转移。
英文摘要
Numerous investigators in both the clinical and basic sciences have postulated that platelets, platelet thrombi, and/or the coagulation cascade play a role in the metastasis of tumor cells. One proposed mechanism is that platelets enhance tumor cell adhesion to endothelial cells or subendothelial matrix during the arrest phase of the metastatic cascade. However, a causal relationship between tumor cells and platelets in the above interactions has not been established. Considerable information does exist for the role of platelet glycoproteins in platelet adhesion to the vessel wall. A causal role for platelet glycoprotein lb and glycoprotein llb/llla and platelet adhesion to the subendothelial matrix is firmly established. We have recently obtained evidence for the presence of immunologically related glycoproteins (lR GP) on the surface of several tumor cell lines. In the present proposal, we will test the following working hypothesis. First, that platelet glycoproteins lb and llb/llla (Gpllb/llla) play a major role in tumor cell-platelet interactions such as tumor cell induced platelet aggregation and platelet enhanced tumor cell adhesion to endothelial cells, extracellular matrix and/or its individual components. Second, that tumor cells possess surface glycoproteins which are lR, if not identical, to platelet GpIB and Gpllb/llla and that these tumor cell glycoproteins (lR Gplb; lR Gpllb/llla) play a major role in tumor cell induced platelet aggregation, tumor cell adhesion to endothelial cells, and tumor cell adhesion to endothelial cell extracellular matrix and/or its individual components. Preliminary data indicate the presence of these glycoproteins on the tumor cell surface by immunofluorescence and immunoelectron microscopic analysis. In addition, a role for the platelet glycoproteins and tumor cell glycoproteins in the interaction between the two cell types and in their subsequent interactions has been obtained. Other evidence suggests the tumor cell cytoskeleton may regulate the expression and function of these tumor cell membrane glycoproteins. In this proposal we will determine the role of lR Gpib and Gpllb/llla in tumor cell adhesion to endothelial cells, extracellular matrix, and its individual components under static conditions and under flow conditions exhibiting different shear rates. In addition, we will determine the role of platelet GpIB and Gpllb/llla in platelet tumor cell interaction and platelet facilitated tumor cell adhesion to biologically relevant substrata. The role of the tumor cell cytoskeleton in these processes will also be examined. Platelet Gpib serves as receptor for thrombin. Therefore, we will determine if tumor cell lR Gplb will function as a thrombin receptor and if thrombin can influence the expression of tumor cell lR Gpllb/llla and affect its functional relationship with the extracellular matrix. Finally we will determine if these tumor cell glycoproteins are heterogenously expressed on cells of different metastatic capabilities and transiently expressed on cells exposed to different environmental conditions. This proposal will therefore seek to establish functional significance for these glycoproteins in biological processes (i.e., adhesion, etc.) relevant to tumor metastasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Thromboxane in Prostate Cancer Progression
  • 批准号:
    7483703
  • 项目类别:
  • 资助金额:
    $27.71万
  • 财政年份:
    2006
  • 负责人:
    KENNETH V HONN
  • 依托单位:
Role of Thromboxane in Prostate Cancer Progression
  • 批准号:
    7275370
  • 项目类别:
  • 资助金额:
    $32.14万
  • 财政年份:
    2006
  • 负责人:
    KENNETH V HONN
  • 依托单位:
Role of Thromboxane in Prostate Cancer Progression
  • 批准号:
    7678047
  • 项目类别:
  • 资助金额:
    $28.22万
  • 财政年份:
    2006
  • 负责人:
    KENNETH V HONN
  • 依托单位:
Role of Thromboxane in Prostate Cancer Progression
  • 批准号:
    7915735
  • 项目类别:
  • 资助金额:
    $28.46万
  • 财政年份:
    2006
  • 负责人:
    KENNETH V HONN
  • 依托单位:
海外基金